<?xml version="1.0" encoding="UTF-8"?>
<ref id="R65">
 <label>65. •</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Bella</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Kaminski</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Mancuso</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Young</surname>
   <given-names>WB</given-names>
  </name>, 
  <name>
   <surname>Chen</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Sariyer</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Fischer</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Amini</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Ferrante</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Jacobson</surname>
   <given-names>JM</given-names>
  </name>
  <etal/>: 
  <article-title>Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice</article-title>. 
  <source>Mol Ther Nucleic Acids</source>
  <year>2018</year>, 
  <volume>12</volume>:
  <fpage>275</fpage>–
  <lpage>282</lpage>.
  <pub-id pub-id-type="pmid">30195766</pub-id>
 </mixed-citation>
 <note>
  <p id="P39">This report describes the targeting of HIV DNA in infected human PBMC engrafted in NOD/SCID mice with an intravenously injected lentiviral vector expressing Cas9 and a multiplex of gRNAs. This in vivo treatment resulted in the editing and removal of proviral DNA.</p>
 </note>
</ref>
